- Home
- SANG vs FENC Comparison
SANG vs FENC Comparison
Compare SANG & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- FENC
- Stock Information
- Founded
- SANG 1984
- FENC 1996
- Country
- SANG Canada
- FENC United States
- Employees
- SANG N/A
- FENC N/A
- Industry
- SANG Computer Software: Programming Data Processing
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SANG Technology
- FENC Health Care
- Exchange
- SANG Nasdaq
- FENC Nasdaq
- Market Cap
- SANG 153.5M
- FENC 156.9M
- IPO Year
- SANG 2021
- FENC 2001
- Fundamental
- Price
- SANG $4.77
- FENC $5.08
- Analyst Decision
- SANG
- FENC Strong Buy
- Analyst Count
- SANG 0
- FENC 2
- Target Price
- SANG N/A
- FENC $14.00
- AVG Volume (30 Days)
- SANG 6.2K
- FENC 87.7K
- Earning Date
- SANG 05-07-2025
- FENC 05-13-2025
- Dividend Yield
- SANG N/A
- FENC N/A
- EPS Growth
- SANG N/A
- FENC N/A
- EPS
- SANG N/A
- FENC N/A
- Revenue
- SANG $241,243,000.00
- FENC $47,538,000.00
- Revenue This Year
- SANG N/A
- FENC $2.68
- Revenue Next Year
- SANG $3.21
- FENC $71.63
- P/E Ratio
- SANG N/A
- FENC N/A
- Revenue Growth
- SANG N/A
- FENC 123.69
- 52 Week Low
- SANG $4.04
- FENC $3.96
- 52 Week High
- SANG $7.99
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- SANG 51.88
- FENC 34.36
- Support Level
- SANG $4.55
- FENC $5.02
- Resistance Level
- SANG $4.76
- FENC $5.50
- Average True Range (ATR)
- SANG 0.20
- FENC 0.41
- MACD
- SANG 0.10
- FENC -0.03
- Stochastic Oscillator
- SANG 89.61
- FENC 22.22
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.